Cardiac MRI in the treatment of arrhythmias

Expert Review of Cardiovascular Therapy

Volumn 11, Issue 7, 2013, Pages 843-851

  Zimmerman, Stefan L ^a   Nazarian, Saman ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ablation; arrhythmia; delayed enhancement; fibrosis; MRI

Indexed keywords

ARTIFICIAL HEART; CARDIAC IMAGING; CATHETER ABLATION; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HUMAN; IONIZING RADIATION; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; CATHETER ABLATION; DECISION MAKING; HUMANS; MAGNETIC RESONANCE IMAGING; TREATMENT OUTCOME;

EID: 84881113786     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2013.811975     Document Type: Review

References (47)

1. Aliot EM, Stevenson WG, Almendral-Garrote JM et al.; European Heart Rhythm Association (EHRA); Registered Branch of the European Society of Cardiology (ESC); Heart Rhythm Society (HRS); American College of Cardiology (ACC); American Heart Association (AHA). EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm 6(6), 886-933 (2009
2. Calkins H, Brugada J, Packer DL et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 4(6), 816-861 (2007
3. Zipes DP, Camm AJ, Borggrefe M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J. Am. Coll. Cardiol. 48(5), e247-e346 (2006
4. Dong J, Dickfeld T, Dalal D et al. Initial experience in the use of integrated electroanatomic mapping with threedimensional MR/CT images to guide catheter ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol. 17(5), 459-466 (2006
5. Gupta S, Desjardins B, Baman T et al. Delayed-enhanced MR scar imaging and intraprocedural registration into an electroanatomical mapping system in post-infarction patients. JACC Cardiovasc. Imaging 5(2), 207-210 (2012
6. Mlcochová H, Tintera J, Porod V, Peichl P, Cihák R, Kautzner J. Magnetic resonance angiography of pulmonary veins: Implications for catheter ablation of atrial fibrillation. Pacing Clin. Electrophysiol. 28(10), 1073-1080 (2005
7. Bunch TJ, Day JD. Novel ablative approach for atrial fibrillation to decrease risk of esophageal injury. Heart Rhythm 5(4), 624-627 (2008
8. Hundley WG, Bluemke DA, Finn JP et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J. Am. Coll. Cardiol. 55(23), 2614-2662 (2010
9. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 57(8), 891-903 (2011
10. Simonetti OP, Kim RJ, Fieno DS et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218(1), 215-223 (2001
11. Lee VS. Cardiovascular MRI: Physical principles to practical protocols. Lippincott Williams & Wilkins, PA, USA (2006
12. Bello D, Fieno DS, Kim RJ et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J. Am. Coll. Cardiol. 45(7), 1104-1108 (2005
13. Nazarian S, Bluemke DA, Lardo AC et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112(18), 2821-2825 (2005
14. Desjardins B, Crawford T, Good E et al. Infarct architecture and characteristics on delayed enhanced magnetic resonance imaging and electroanatomic mapping in patients with postinfarction ventricular arrhythmia. Heart Rhythm 6(5), 644-651 (2009
15. Ashikaga H, Sasano T, Dong J et al. Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: Implications for catheter ablation. Circ. Res. 101(9), 939-947 (2007
16. Verma A, Marrouche NF, Schweikert RA et al. Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia post-myocardial infarction. J. Cardiovasc. Electrophysiol. 16(5), 465-471 (2005
17. Estner HL, Zviman MM, Herzka D et al. The critical isthmus sites of ischemic ventricular tachycardia are in zones of tissue heterogeneity, visualized by magnetic resonance imaging. Heart Rhythm 8(12), 1942-1949 (2011
18. Andreu D, Berruezo A, Ortiz-Pérez JT et al. Integration of 3D electroanatomic maps and magnetic resonance scar characterization into the navigation system to guide ventricular tachycardia ablation. Circ. Arrhythm. Electrophysiol. 4(5), 674-683 (2011
19. Schmidt A, Azevedo CF, Cheng A et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 115(15), 2006-2014 (2007
20. Roes SD, Borleffs CJ, van der Geest RJ et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ. Cardiovasc. Imaging 2(3), 183-190 (2009
21. Yan AT, Shayne AJ, Brown KA et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114(1), 32-39 (2006
22. Boyé P, Abdel-Aty H, Zacharzowsky U et al. Prediction of life-Threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR. JACC Cardiovasc. Imaging 4(8), 871-879 (2011
23. McGann CJ, Kholmovski EG, Oakes RS et al. New magnetic resonance imagingbased method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J. Am. Coll. Cardiol. 52(15), 1263-1271 (2008
24. Peters DC, Wylie JV, Hauser TH et al. Detection of pulmonary vein and left atrial scar after catheter ablation with threedimensional navigator-gated delayed enhancement MR imaging: Initial experience. Radiology 243(3), 690-695 (2007
25. Badger TJ, Daccarett M, Akoum NW et al. Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: Lessons learned from delayed-enhancement MRI in repeat ablation procedures. Circ. Arrhythm. Electrophysiol. 3(3), 249-259 (2010
26. Oakes RS, Badger TJ, Kholmovski EG et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119(13), 1758-1767 (2009
27. Seitz J, Horvilleur J, Lacotte J et al. Correlation between AF substrate ablation difficulty and left atrial fibrosis quantified by delayed-enhancement cardiac magnetic resonance. Pacing Clin. Electrophysiol. 34(10), 1267-1277 (2011
28. Nazarian S, Roguin A, Zviman MM et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 114(12), 1277-1284 (2006
29. Scheffler K, Lehnhardt S. Principles and applications of balanced SSFP techniques. Eur. Radiol. 13(11), 2409-2418 (2003
30. Wright J, Adriaenssens T, Dymarkowski S, Desmet W, Bogaert J. Quantification of myocardial area at risk with T2-weighted CMR: Comparison with contrast-enhanced CMR and coronary angiography. JACC Cardiovasc. Imaging 2(7), 825-831 (2009
31. Vignaux O, Dhote R, Duboc D et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: Initial results of a prospective study. J. Comput. Assist. Tomogr. 26(5), 762-767 (2002
32. Friedrich MG, Sechtem U, Schulz-Menger J et al.; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J. Am. Coll. Cardiol. 53(17), 1475-1487 (2009
33. Abdel-Aty H, Cocker M, Strohm O, Filipchuk N, Friedrich MG. Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: Regional distribution and relation to late gadolinium enhancement and severity of hypertrophy. J. Magn. Reson. Imaging 28(1), 242-245 (2008
34. Prasad SK, Pennell DJ. Safety of cardiovascular magnetic resonance in patients with cardiovascular implants and devices. Heart 90(11), 1241-1244 (2004
35. Nazarian S, Hansford R, Roguin A et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann. Intern. Med. 155(7), 415-424 (2011
36. Naehle CP, Strach K, Thomas D et al. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverterdefibrillators. J. Am. Coll. Cardiol. 54(6), 549-555 (2009
37. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J. Am. Coll. Cardiol. 43(7), 1315-1324 (2004
38. Shinbane JS, Colletti PM, Shellock FG. Magnetic resonance imaging in patients with cardiac pacemakers: Era of 'MR conditional' designs. J. Cardiovasc. Magn. Reson. 13, 63 (2011
39. Beinart R, Nazarian S. Magnetic resonance imaging in patients with implanted devices. J. Cardiovasc. Electrophysiol. 23(9), 1040-1042 (2012
40. Sasaki T, Hansford R, Zviman MM et al. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators. Circ. Cardiovasc. Imaging 4(6), 662-670 (2011
41. Dickfeld T, Tian J, Ahmad G et al. MRI-Guided ventricular tachycardia ablation: Integration of late gadoliniumenhanced 3D scar in patients with implantable cardioverter-defibrillators. Circ. Arrhythm. Electrophysiol. 4(2), 172-184 (2011
42. Nazarian S, Kolandaivelu A, Zviman MM et al. Feasibility of real-Time magnetic resonance imaging for catheter guidance in electrophysiology studies. Circulation 118(3), 223-229 (2008
43. Schmidt EJ, Mallozzi RP, Thiagalingam A et al. Electroanatomic mapping and radiofrequency ablation of porcine left atria and atrioventricular nodes using magnetic resonance catheter tracking. Circ. Arrhythm. Electrophysiol. 2(6), 695-704 (2009
44. Vergara GR, Vijayakumar S, Kholmovski EG et al. Real-Time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla. Heart Rhythm 8(2), 295-303 (2011
45. Hoffmann BA, Koops A, Rostock T et al. Interactive real-Time mapping and catheter ablation of the cavotricuspid isthmus guided by magnetic resonance imaging in a porcine model. Eur. Heart J. 31(4), 450-456 (2010
46. Nordbeck P, Beer M, Köstler H et al. Cardiac catheter ablation under real-Time magnetic resonance guidance. Eur. Heart J. 33(15), 1977 (2012
47. Sommer P, Grothoff M, Eitel C et al. Feasibility of real-Time magnetic resonance imaging-guided electrophysiology studies in humans. Europace 15(1), 101-108 (2013